OBJECTIVE. The objectiveof this paper is to describea new finding on CT of hepatic and portal vein segments located in a subcapsular location on the surface of the liver.SUBJECTS AND METHODS. From a seriesof more than I I .000 contrast-enhanced abdominalCT scansperformedfrom 1993 to 1997, 14 patientswere identifiedashavinghe patic or portal vein segments or both in a subcapsular location on the surface of the liver.RESULTS. We found sevenportalvein surfacesegmentsin sevenpatientsand 14 hepatic vein surface segments in 12 patients. Ufthe 14 patients, five had both portal and hepatic vein surface segments. Therefore, in a cohort that exceeded 11,000 patients, the incidence of this finding was 0.1%. Four patients had cirrhosis, two had small hypervascular liver lesions, and eighthadhealthylivers.The surfaceveinswere not associated with any otherrecognizedvas cular anomalies or with anastomoses to extrahepatic systemic veins.CONCLUSION. Hepaticandportalveinscancourseto a subcapsular locationon the sur faceof theliver.Thisanatomyisbelievedto bea normalvariantandcanbefoundin patientswith healthyliversandnormalhepaticveinhemodynamics andin patientswith portalhypertension.
T his paper describes a new vascularanatomic variant observed on CT:hepaticand portal veinscoursing in a subcapsular location and protruding from the surface of the liver. To our knowledge, this finding has not been reported previously in the radiology or anatomy literature.
Subjects and MethodsThe findingofan enlargedhepaticveinextending to and protruding from the surface of the liver was first recognized on CT at our institution in October 1993.
Abdominal CT was performed with a HiSpeedAdvantage helical scanner (General Electric Medical Systems, Milwaukee, WI) with 3-to 5-mm collima flon,helical technique, andvariable pitchto image the entire liver in a single breath-hold. Two protocols were used for contrast enhancement. Single-phase (portal venous phase) helical scanning was per formedusinga SmartPrep(GeneralElectricMedical Systems) scan delay with a hepatic threshold of 50â€" 70 H duringIV powerinjectionof 150-200 ml of ioversol (320 mg I/ml) at 3â€"5 mI/sec. Dual-phase helical scanning (arterial and portal venous phases) was performed using an initial test bolus of 20 ml of ioversoladministeredthroughan 18-to 19-gaugean tecubitalvein at a rate of 5 mI/secusing a power in jector. During the test bolus. low-dose axial scans were obtained at the level ofthe celiac artery (the Tl2 vertebra). Using scanner software, a cursor was placedon the aorta,and time to peak aorticenhance mentwas calculatedand displayedgraphically. A bo lus of 180ml of ioversol was then power-injectedat 5 mI/sec.Arterialphase imagingwas initiatedeitherat time to aortic peak plus 5 sec or at time to aortic peak minus 2 sec, and portal venous phase imaging was initiated60 sec afterthe startof the administrationof the bolus of contrast material.Arterial phase scans were initiated at peak minus 2 sec specifically for ac quiring axial images for three-dimensional (3D) CT angiograph...